Funded Tech Companies

Grey Wolf Therapeutics

Based in Abingdon, Grey Wolf Therapeutics has funding from Pfizer Venture Investments, ICG Ventures and Oxford Science Enterprises.

Company Overview

Company Name
Grey Wolf Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Milton Park Innovation Centre 99 Park Drive, Milton Park
Abingdon, OX14 4RY
UK
Email Address

Company Background Information

Overview
Grey Wolf is a UK and Australian-based drug discovery and development company focused on developing novel immuno-oncology agents. The company was founded in 2017 by experienced industry professionals; Tom McCarthy (Executive Chairman; former President and CEO of Spinifex Pharmaceuticals), and Peter Joyce (CEO; former Project Leader at Vertex Pharmaceuticals).?
Profile
Grey Wolf Therapeutics LinkedIn Company Profile
Social Media
Grey Wolf Therapeutics Company Twitter Account
Company News
Grey Wolf Therapeutics News
Facebook
Grey Wolf Therapeutics on Facebook
YouTube
Grey Wolf Therapeutics on YouTube
Last Transaction
5/23/2024

Financing History

Date
Type
Amount
Venture Equity
$50,000,000
Venture Equity
$49,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Joyce
  Peter Joyce LinkedIn Profile  Peter Joyce Twitter Account  Peter Joyce News  Peter Joyce on Facebook
Co-Founder
Thomas McCarthy
  Thomas McCarthy LinkedIn Profile  Thomas McCarthy Twitter Account  Thomas McCarthy News  Thomas McCarthy on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Grey | Greycork

 

Share this article

 


About Our VC Deals Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary